Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 

More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 

Implanting the Barostim device is now associated with an average payment amount of $45,000, up significantly from the previous average of $29,000.

IVUS was especially effective when treating patients with a complex coronary anatomy, researchers found. 

Could this late-breaking clinical trial from TCT 2023 be a sign of things to come in the years ahead? Samir Kapadia, MD, explored the topic in a new interview. 

CLAiR offers physicians another way to evaluate a patient’s cardiovascular health: non-invasive retinal images captured during routine eye exams.

After 12 months, researchers found that the device was associated with control of AFib in 99% of patients and relief from AFib symptoms in 93.1% of patients.

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

Experts believe the data underline the need for reform, granting radiologists RVUs for this work and hiring more physicians to help ease the burden. 

The Plantation, Florida-based imaging center operator recently reached “important milestones” in its comeback from a debilitating October cyberattack.